Aarti Drugs Limited — Call Transcript 2021

May 13, 2021

==> picture [477 x 82] intentionally omitted <==

Ref: ADL/SE/2021-22

May 13, 2021

To, Listing/ Compliance Department BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

To,

Listing/ Compliance Department National Stock Exchange of India Limited, “Exchange Plaza”, Bandra - Kurla Complex, Bandra (E), Mumbai – 400051

BSE CODE – 524348

NSE SYMBOL: AARTIDRUGS

Dear Sir/Madam,

Ref : Regulation 30(6) of SEBI (LODR) Regulations, 2015 Sub: Intimation of Conference Call

This is to inform you that Conference Call for the Investors and Analysts has been scheduled on Monday, May 17, 2021 at 4:00 PM IST to discuss the Company’s financial performance for the Quarter and year ended March 31, 2021. Please find attached herewith invitation for the same.

Kindly take the same on record.

Thanking you,

Yours faithfully,

FOR AARTI DRUGS LIMITED

==> picture [88 x 35] intentionally omitted <==

RUSHIKESH DEOLE

==> picture [75 x 71] intentionally omitted <==

COMPANY SECRETARY & COMPLIANCE OFFICER ICSI M.No.: A54527

==> picture [468 x 32] intentionally omitted <==

==> picture [117 x 54] intentionally omitted <==

Aarti Drugs Limited

Cordially invites you to

Conference Call

To discuss the financial performance for Quarter & Year ended 31[st] March, 2021

Day/Date : Monday, 17[th] May, 2021 Time : 4:00 PM, IST

Primary Number:	+91 22 6280 1309
	+91 22 7115 8210
Toll Free Number:	Hongkong – 800964448
	Singapore – 8001012045
	UK – 08081011573
	US – 18667462133

Diamond Pass : Please Click here to express join the Call

Participants:

Mr. Harshit Savla – Jt. Managing Director Mr. Harit Shah – Wholetime Director

Mr. Adhish Patil – Chief Finance Officer Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

We look forward to your participation

RSVP

Jigar Kavaiya / Chinmay Madgulkar, Strategic Growth Advisors Pvt. Ltd., Contact: +91 99206 02034/ 98600 88296